Atellica IM Homocysteine Calibrator (2 Pack). Siemens Material Number: 10995498 Recall
Atellica IM Homocysteine Calibrator (2 Pack). Siemens Material Number: 10995498
FDA recall Class II
Ongoing
FDA lists this Class II recall for Atellica IM Homocysteine Calibrator (2 Pack). Siemens Material Number: 10995498. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1821-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Apr 15, 2025
- FDA report date
- Jun 4, 2025
- Quantity in commerce
- 2,212 packs (4,424 units) - 448 packs US, 1,764 packs OUS
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Atellica IM Homocysteine Calibrator (2 Pack). Siemens Material Number: 10995498
Affected model & UDI checker
Search the exact identifiers published for Z-1821-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Atellica IM Homocysteine Calibrator (2 Pack). Siemens Material Number: 10995498 | Check source notice | 00630414598253 |
FDA code information
Siemens Material Number: 10995498. UDI-DI: 00630414598253 Kit lot numbers: 86236A74, 44206A75. ***Updated 5/8/26*** Additional Lots 25675A77, 44505A78, 52364A79.
Why was this product recalled?
Certain lots of Atellica IM Homocysteine Calibrator and ADVIA Centaur HCY Calibrator do not meet the assay Instructions for Use (IFU) reference interval due to calibrator instability resulting in increased positive bias.
What actions did Siemens Healthcare Diagnostics, Inc. take?
An Urgent Medical Device Correction (UMDC) was mailed to all US affected customers by FedEx, and an Urgent Field Safety Notice (UFSN) was issued to all OUS Siemens reporting sites with affected customers on about 04/15/2025. Customers were instructed to review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, discontinue use of and discard the affected devices, and complete and return the Effectiveness Check questionnaire. Customers were also instructed to forward the letter to those who may have received the affected devices. ***Updates: ***On 10/21/25, a second notice was mailed to all affected US customers to inform them that an additional lot was added to the scope of the recall. Kit lots ending in 77 are affected. ***On 5/1/26, a third notice was mailed to all affected US customers to inform them that an additional affected lot was added. Kit lots ending in 78 and 79 are affected.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1821-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology